193 related articles for article (PubMed ID: 23839042)
1. Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells.
Pincini A; Tornillo G; Orso F; Sciortino M; Bisaro B; Leal Mdel P; Lembo A; Brizzi MF; Turco E; De Pittà C; Provero P; Medico E; Defilippi P; Taverna D; Cabodi S
Cell Cycle; 2013 Aug; 12(15):2409-22. PubMed ID: 23839042
[TBL] [Abstract][Full Text] [Related]
2. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.
Tornillo G; Bisaro B; Camacho-Leal Mdel P; Galiè M; Provero P; Di Stefano P; Turco E; Defilippi P; Cabodi S
Eur J Cell Biol; 2011; 90(2-3):237-48. PubMed ID: 20961652
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.
Sciortino M; Camacho-Leal MDP; Orso F; Grassi E; Costamagna A; Provero P; Tam W; Turco E; Defilippi P; Taverna D; Cabodi S
Sci Rep; 2017 Apr; 7(1):1145. PubMed ID: 28442738
[TBL] [Abstract][Full Text] [Related]
4. p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.
Bisaro B; Sciortino M; Colombo S; Camacho Leal MP; Costamagna A; Castellano I; Montemurro F; Rossi V; Valabrega G; Turco E; Defilippi P; Cabodi S
Oncotarget; 2016 Jan; 7(4):4442-53. PubMed ID: 26716506
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.
Yu M; Lin G; Arshadi N; Kalatskaya I; Xue B; Haider S; Nguyen F; Boutros PC; Elson A; Muthuswamy LB; Tonks NK; Muthuswamy SK
Mol Cell Biol; 2012 Oct; 32(19):3913-24. PubMed ID: 22851698
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.
Kang H; Kim C; Lee H; Rho JG; Seo JW; Nam JW; Song WK; Nam SW; Kim W; Lee EK
Cell Death Differ; 2016 Mar; 23(3):484-95. PubMed ID: 26337669
[TBL] [Abstract][Full Text] [Related]
7. p130Cas is an essential transducer element in ErbB2 transformation.
Cabodi S; Tinnirello A; Bisaro B; Tornillo G; del Pilar Camacho-Leal M; Forni G; Cojoca R; Iezzi M; Amici A; Montani M; Eva A; Di Stefano P; Muthuswamy SK; Tarone G; Turco E; Defilippi P
FASEB J; 2010 Oct; 24(10):3796-808. PubMed ID: 20505116
[TBL] [Abstract][Full Text] [Related]
8. Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer.
Jin L; Wessely O; Marcusson EG; Ivan C; Calin GA; Alahari SK
Cancer Res; 2013 May; 73(9):2884-96. PubMed ID: 23338610
[TBL] [Abstract][Full Text] [Related]
9. Effects of ErbB2 Overexpression on the Proteome and ErbB Ligand-specific Phosphosignaling in Mammary Luminal Epithelial Cells.
Worthington J; Spain G; Timms JF
Mol Cell Proteomics; 2017 Apr; 16(4):608-621. PubMed ID: 28174229
[TBL] [Abstract][Full Text] [Related]
10. LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling.
Chang J; Nicolau MM; Cox TR; Wetterskog D; Martens JW; Barker HE; Erler JT
Breast Cancer Res; 2013; 15(4):R67. PubMed ID: 23971878
[TBL] [Abstract][Full Text] [Related]
11. Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
Costamagna A; Rossi Sebastiano M; Natalini D; Simoni M; Valabrega G; Defilippi P; Visentin S; Ermondi G; Turco E; Caron G; Cabodi S
Sci Rep; 2019 Feb; 9(1):3089. PubMed ID: 30816273
[TBL] [Abstract][Full Text] [Related]
12. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
13. miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells.
He XH; Zhu W; Yuan P; Jiang S; Li D; Zhang HW; Liu MF
Oncogene; 2016 Nov; 35(46):6015-6025. PubMed ID: 27065318
[TBL] [Abstract][Full Text] [Related]
14. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
[TBL] [Abstract][Full Text] [Related]
15. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.
Scott GK; Goga A; Bhaumik D; Berger CE; Sullivan CS; Benz CC
J Biol Chem; 2007 Jan; 282(2):1479-86. PubMed ID: 17110380
[TBL] [Abstract][Full Text] [Related]
16. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ
Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
Peng M; Ball-Kell SM; Tyner AL
Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
[TBL] [Abstract][Full Text] [Related]
18. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells.
Ryo A; Liou YC; Wulf G; Nakamura M; Lee SW; Lu KP
Mol Cell Biol; 2002 Aug; 22(15):5281-95. PubMed ID: 12101225
[TBL] [Abstract][Full Text] [Related]
19. ErbB2-enhanced invasiveness of H-Ras MCF10A breast cells requires MMP-13 and uPA upregulation via p38 MAPK signaling.
Yong HY; Kim IY; Kim JS; Moon A
Int J Oncol; 2010 Feb; 36(2):501-7. PubMed ID: 20043086
[TBL] [Abstract][Full Text] [Related]
20. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
Shan X; Wen W; Zhu D; Yan T; Cheng W; Huang Z; Zhang L; Zhang H; Wang T; Zhu W; Zhu Y; Zhu J
PLoS One; 2017; 12(1):e0170298. PubMed ID: 28099468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
